Levobupivacaine (LBV)
Levobupivacaine is a local anaesthetic drug belonging to the amino amide group. It is the S-enantiomer of bupivacaine. Compared to bupivacaine, levobupivacaine is associated with less vasodilation and has a longer duration of action. It is approximately 13 percent less potent (by molarity) than racemic bupivacaine. Levobupivacaine is indicated for local anaesthesia including infiltration, nerve block, ophthalmic, epidural and intrathecal anaesthesia in adults; and infiltration analgesia in children. Systemic exposure to excessive quantities of bupivacaine mainly result in central nervous system (CNS) and cardiovascular effects – CNS effects usually occur at lower blood plasma concentrations and additional cardiovascular effects present at higher concentrations, though cardiovascular collapse may also occur with low concentrations.
Organism species: Pan-species (General)
- Customized Service n/a Complete Antigen of Levobupivacaine (LBV) Antigenic Transformation Customized Service Offer
- Customized Service n/a Monoclonal Antibody to Levobupivacaine (LBV) Monoclonal Antibody Customized Service Offer
- Customized Service n/a Polyclonal Antibody to Levobupivacaine (LBV) Polyclonal Antibody Customized Service Offer
- Customized Service n/a CLIA Kit for Levobupivacaine (LBV) CLIA Kit Customized Service Offer
- Customized Service n/a ELISA Kit for Levobupivacaine (LBV) ELISA Kit Customized Service Offer
